14th Conference on Retroviruses and Opportunistic Infections

HIV Treatment Bulletin - Vol. 8, No. 6/7, June-July 2007

25-28 February 2007, Los Angeles

Our final reports from this meeting include:

• Protease inhibitors in pregnancy
• IDU-related studies at CROI:

• Low Rates of HCV treatment among eligible injection drug users;
• Effect of HCV and HIV on mortality among injecting drug users;
• HCV/HIV-co-infected IDUs are at increased risk of death from hepatitis-related death in the HAART era, compared with HCV-mono-IDUs;
• Long-term effectiveness of isoniazid prophylaxis on TB incidence in a cohort of IDUs;
• The dynamics of HCV transmission among injection drug users in St. Petersburg;
• “Founder effect” among HIV-positive IDUs in Karachi, Pakistan;

2007-06-10
IB070806-13

©2007. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.